Beijing Health Guard Biotechnology (BJSE:920575) GF Score: 47/100 (As of Aug. 27, 2026) — 161% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920575 Beijing Health Guard Biotechnology Inc BJSE:920575
47 GF Score
Price ¥5.59
GF Value ¥7.92
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Beijing Health Guard Biotechnology GF Score?

Beijing Health Guard Biotechnology BJSE:920575 47 GF Score is 47 as of Aug. 27, 2026, which is 161% above its 10-year median of 18.00. GuruFocus rates BJSE:920575 with a GF Score™ of 47/100 and a GF Value™ of ¥7.92 (Modestly Undervalued). The stock has 10 warning signs investors should review.

Beijing Health Guard Biotechnology has the GF Score of 47, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 1/10
2. Profitability Rank : 3/10
3. Growth Rank : 7/10
4. GF Value Rank : 4/10
5. Momentum Rank : 1/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Beijing Health Guard Biotechnology might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Beijing Health Guard Biotechnology  (BJSE:920575) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Beijing Health Guard Biotechnology GF Score Related Terms

BJSE:920575 vs VRTX, REGN, RVMD: GF Score Comparison

For the Biotechnology subindustry, Beijing Health Guard Biotechnology's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Health Guard Biotechnology GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Health Guard Biotechnology's GF Score distribution charts can be found below:

* The bar in red indicates where Beijing Health Guard Biotechnology's GF Score falls into.


BJSE:920575
47GF Score
Beijing Health Guard Biotechnology Inc BJSE:920575
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 47 mean?
Beijing Health Guard Biotechnology (BJSE:920575) has a GF Score of 47 as of Aug. 27, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Beijing Health Guard Biotechnology and its competitors. This is 161% above median its historical median of 18.00. Over the past decade, Beijing Health Guard Biotechnology's GF Score has ranged from 4.00 to 44.00.
Is Beijing Health Guard Biotechnology's GF Score too high?
Beijing Health Guard Biotechnology's current GF Score of 47 is 161% above median its 10-year median of 18.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 44.00. Overall, Beijing Health Guard Biotechnology has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Health Guard Biotechnology's GF Score compare to VRTX and REGN?
Beijing Health Guard Biotechnology's GF Score of 47 can be compared against companies in the Biotechnology industry. Historically, Beijing Health Guard Biotechnology's own GF Score has ranged from 4.00 to 44.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Beijing Health Guard Biotechnology and its competitors. Beijing Health Guard Biotechnology's current GF Score is 47, which is 161% above median its own 10-year median of 18.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Health Guard Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, Beijing Health Guard Biotechnology (BJSE:920575) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥7.92, compared to a current price of ¥5.59 — trading 29.4% below its estimated fair value. The current GF Score is 47, which is 161% above median its 10-year median of 18.00. Beijing Health Guard Biotechnology's overall GF Score™ is 47/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Beijing Health Guard Biotechnology (BJSE:920575), the current GF Score is 47 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Health Guard Biotechnology (BJSE:920575) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Health Guard Biotechnology stock appears to be undervalued. The current stock price of ¥5.59 is trading 29.4% below its estimated GF Value™ of ¥7.92. GuruFocus considers Beijing Health Guard Biotechnology to be Modestly Undervalued.

Key valuation signals for BJSE:920575:

  • GF Score: 47 (161% above median its 10-year median of 18.00)
  • GF Value™: ¥7.92 vs. price of ¥5.59 (29.4% below fair value)
  • GF Score™: 47/100 with 10 warning signs

No single metric tells the full story. See the BJSE:920575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Health Guard Biotechnology Business Description

Address No. 7 Rongchang East Street, Beijing Economic and Technological Development Zone, Room 201 and 202, Building A2, Beijing, CHN, 100176
Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.
47GF Score

Get the complete analysis for BJSE:920575

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.59
Price
¥7.92
GF Value